Janux Therapeutics Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $65.60 on 05/03/24, while the lowest price for the same period was registered at $7.79 on 02/05/24.
52-week price history of JANX Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Janux Therapeutics Inc’s current trading price is -38.75% away from its 52-week high, while its distance from the 52-week low is 415.79%. The stock’s price range during this period has spanned from $7.79 to $65.60. In the Healthcare sector, the Janux Therapeutics Inc’s shares surpassed a trading volume of approximately 2.61 million for the day, which was noticeably higher compared to the average daily volume of 9.0.65 million over the past three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Market Capitalization and Financial Performance: An In-Depth Look
Janux Therapeutics Inc (JANX) has experienced a quarterly decline of -10.73% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.06B and boasts a workforce of 64 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 46.59, with a change in price of -2.10. Similarly, Janux Therapeutics Inc recorded 626,505 in trading volume during the last 100 days, posting a change of -4.97%.
Examining JANX’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for JANX stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.03.
JANX Stock Stochastic Average
Today’s raw stochastic average for Janux Therapeutics Inc over the last 50 days is 0.90%.This indicates a increase from the raw stochastic average of the past 20 days, which was 0.90%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 1.59% and 4.05%, respectively.
JANX Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Until today this year the stock’s price performance recorded an increase of 274.46%. However, over the last six months, the performance has been stronger by -26.92%. The price of JANX decreased -25.58% over the last 30 days. And in the last five days, it has fallen by -20.14%.
